Centessa Pharmaceuticals plc (CNTA) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 348.68M | 367.88M | 307.68M | 300.36M | 347.72M | 536.41M | 568.36M | 355.5M | 284.48M | 315.09M | 332.45M | 350.41M |
| Cash & Short-Term Investments | 276.59M | 294.58M | 246.21M | 250.72M | 284.5M | 482.18M | 518.45M | 294.83M | 230.18M | 256.55M | 281.34M | 303.59M |
| Cash Only | 62.43M | 61.3M | 50.81M | 44.24M | 105.16M | 383.22M | 395.03M | 127.37M | 118.22M | 128.03M | 171.5M | 145.22M |
| Short-Term Investments | 214.16M | 233.28M | 195.4M | 206.48M | 179.35M | 98.96M | 123.42M | 167.46M | 111.96M | 128.52M | 109.84M | 158.37M |
| Accounts Receivable | 0 | 0 | 52.21M | 44.1M | 52.7M | 45.3M | 40.04M | 46.99M | 37.17M | 39.15M | 30.39M | 28.42M |
| Days Sales Outstanding | - | - | - | - | 294 | - | - | - | - | 466.77 | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 72.09M | 73.3M | 2.76M | 1.62M | 1.61M | 1.78M | 2.67M | 1.95M | 1.8M | 1.62M | 2.86M | 3.87M |
| Total Non-Current Assets | 293.08M | 319.62M | 140.63M | 191.76M | 180.13M | 40.39M | 41.35M | 43.34M | 43.7M | 45.15M | 44.91M | 42.51M |
| Property, Plant & Equipment | 10.52M | 10.85M | 11.19M | 11.27M | 11.46M | 11.76M | 12.06M | 12.37M | 12.65M | 12.95M | 13.23M | 13.49M |
| Fixed Asset Turnover | - | - | - | - | 1.29x | - | - | - | - | 0.52x | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 257.12M | 282.55M | 102.83M | 153.41M | 140.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.28M | 1.44M | 1.59M | 1.72M | 1.88M | 2.05M | 2.23M | 2.38M | 1.88M | 2.55M | 2.1M | 2.27M |
| Total Assets | 641.76M | 687.5M | 448.3M | 492.13M | 527.85M | 576.8M | 609.72M | 398.85M | 328.17M | 360.25M | 377.36M | 392.92M |
| Asset Turnover | - | - | - | - | 0.03x | - | - | - | - | 0.02x | - | - |
| Asset Growth % | 21.58% | 19.19% | -26.47% | 23.39% | 60.84% | 60.11% | 61.57% | 1.51% | -18.74% | -18.92% | -21.28% | -24.59% |
| Total Current Liabilities | 36.57M | 42.94M | 29.12M | 29.69M | 24.2M | 58M | 26.41M | 26.75M | 27.43M | 39.38M | 34.95M | 33.87M |
| Accounts Payable | 10.66M | 7.58M | 8.68M | 5.69M | 5.13M | 7.14M | 7.44M | 5.32M | 7.5M | 11.81M | 10.85M | 11.09M |
| Days Payables Outstanding | 3.44K | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 25.92M | 35.35M | 6.26M | 4.2M | 2.77M | 10.18M | 6.57M | 644K | 528K | 7.57M | 159K | 507K |
| Current Ratio | 9.53x | 8.57x | 10.57x | 10.12x | 14.37x | 9.25x | 21.52x | 13.29x | 10.37x | 8.00x | 9.51x | 10.35x |
| Quick Ratio | 9.53x | 8.57x | 10.57x | 10.12x | 14.37x | 9.25x | 21.52x | 13.29x | 10.37x | 8.00x | 9.51x | 10.35x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 117.84M | 117.7M | 117.6M | 117.51M | 117.4M | 117.25M | 84.17M | 85.13M | 85.57M | 84.62M | 83.02M | 82.45M |
| Long-Term Debt | 7.37M | 7.57M | 109.82M | 109.55M | 109.25M | 108.94M | 75.7M | 76.5M | 76.8M | 75.7M | 74M | 73.3M |
| Capital Lease Obligations | 0 | 0 | 7.76M | 7.94M | 8.12M | 8.29M | 8.44M | 8.6M | 8.74M | 8.89M | 9.02M | 9.15M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 110.47M | 110.12M | 29K | 29K | 29K | 29K | 29K | 29K | 29K | 29K | 0 | 0 |
| Total Liabilities | 154.41M | 160.63M | 146.73M | 147.21M | 141.6M | 175.25M | 110.58M | 111.88M | 113.01M | 124M | 117.97M | 116.31M |
| Total Debt | 7.37M | 7.57M | 118.26M | 118.14M | 118M | 117.23M | 84.72M | 85.65M | 86.07M | 84.59M | 83.5M | 82.91M |
| Net Debt | -55.06M | -53.73M | 67.45M | 73.9M | 12.84M | -266M | -310.31M | -41.72M | -32.15M | -43.44M | -88M | -62.31M |
| Debt / Equity | 0.02x | 0.01x | 0.39x | 0.34x | 0.31x | 0.29x | 0.17x | 0.30x | 0.40x | 0.36x | 0.32x | 0.30x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -29.21x | -31.10x | -17.94x | -16.19x | -7.60x | -43.49x | -15.41x | -16.07x | -13.85x | -12.89x | -15.32x | -18.97x |
| Total Equity | 487.35M | 526.86M | 301.57M | 344.92M | 386.25M | 401.55M | 499.14M | 286.96M | 215.16M | 236.24M | 259.39M | 276.61M |
| Equity Growth % | 26.18% | 31.21% | -39.58% | 20.2% | 79.51% | 69.97% | 92.43% | 3.74% | -26.63% | -29.72% | -30.44% | -34.15% |
| Book Value per Share | 3.17 | 3.88 | 2.25 | 2.58 | 2.90 | 3.04 | 4.29 | 2.62 | 2.15 | 2.41 | 2.68 | 2.91 |
| Total Shareholders' Equity | 487.35M | 526.86M | 301.57M | 344.92M | 386.25M | 401.55M | 499.14M | 286.96M | 215.16M | 236.24M | 259.39M | 276.61M |
| Common Stock | 419K | 405K | 364K | 363K | 362K | 359K | 357K | 309K | 277K | 273K | 271K | 266K |
| Retained Earnings | -1.27B | -1.19B | -1.12B | -1.07B | -1.01B | -988.7M | -877.37M | -834.81M | -790.99M | -752.95M | -716.11M | -677.46M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 1.41M | 2.71M | 2.6M | 1.59M | 2.08M | 4.21M | 2.1M | 1.59M | 1.62M | 1.49M | 779K | 946K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |